Status:
COMPLETED
Effects of Cranberry Powder Supplements on Gut Microbiota Diversity and Metabolic Syndrome
Lead Sponsor:
Laval University
Collaborating Sponsors:
Naturex
Conditions:
Overweight
Insulin Resistance
Eligibility:
MALE
18-60 years
Phase:
NA
Brief Summary
It is of major importance to refine prevention strategies in order to alleviate inflammation, insulin resistance and metabolic syndrome and it appear that improving gut health and microbiota represent...
Detailed Description
Over the past decade it has become clear that the gut microbiota is a key determinant of obesity and that its perturbations by nutritional insults play a significant role in the development of metabol...
Eligibility Criteria
Inclusion
- overweight
- fasting insulin \> 42 pmol/L
- non smoking
- Stable weight in the past 3 months
Exclusion
- chronic diseases
- Taking drugs that could affect glucose or lipid metabolism
- Taking anti-inflammatory, immunosuppressant or anticoagulant drugs
- Inflammatory bowel disease
- vegetarians, vegan or following any restrictive dietary pattern or if they are big consumers of berries (\>1 portion/day)
- taking pre- and probiotics
- antibiotics in the past 3 months or change in their regular medication
- Major surgery in the past 3 months
- taste aversion for cranberries or cranberry allergy or allergies to other ingredients used in the placebo
Key Trial Info
Start Date :
October 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2020
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT03754504
Start Date
October 15 2018
End Date
March 1 2020
Last Update
March 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut sur la nutrition et les aliments fonctionnels
Québec, Canada, G1V 0A6